Carsten Brockmeyer
Nessuna posizione attualmente
Storia della carriera di Carsten Brockmeyer
Precedenti posizioni note di Carsten Brockmeyer
Società | Posizione | Inizio | Fine |
---|---|---|---|
FORMYCON AG | Amministratore Delegato | - | 30/06/2022 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1991 | 01/01/1998 |
Hexal Biotech Forschungs GmbH | Corporate Officer/Principal | 01/01/1999 | - |
Baxter Deutschland GmbH
Baxter Deutschland GmbH Financial ConglomeratesFinance Part of Baxter International, Inc., Baxter Deutschland GmbH is a German company that changes the lives of millions of people around the world every day. The company is based in Unterschleißheim, Germany. Baxter's products and therapies are used in hospitals and clinics, from the emergency room to the operating room, from the pharmacy to the intensive care unit, improving the care of patients at home. The company's focus on corporate governance is crucial in today's business environment, where investor and public confidence in the company is no longer based solely on financial performance or products and services. Baxter helps maximize safety, streamline procedures, and establish cost efficiencies throughout the clinic. The company was founded in 1960, and the CEO is Christian Wrabetz. | Corporate Officer/Principal | - | - |
Brockmeyer Biopharma GmbH | Fondatore | 01/10/2010 | - |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Corporate Officer/Principal | - | - |
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | 01/01/1998 | - |
Formazione di Carsten Brockmeyer
Hannover Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 7 |
Stati Uniti | 2 |
Svizzera | 2 |
Posizioni
Corporate Officer/Principal | 5 |
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
FORMYCON AG | Health Technology |
Aziende private | 5 |
---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
Baxter Deutschland GmbH
Baxter Deutschland GmbH Financial ConglomeratesFinance Part of Baxter International, Inc., Baxter Deutschland GmbH is a German company that changes the lives of millions of people around the world every day. The company is based in Unterschleißheim, Germany. Baxter's products and therapies are used in hospitals and clinics, from the emergency room to the operating room, from the pharmacy to the intensive care unit, improving the care of patients at home. The company's focus on corporate governance is crucial in today's business environment, where investor and public confidence in the company is no longer based solely on financial performance or products and services. Baxter helps maximize safety, streamline procedures, and establish cost efficiencies throughout the clinic. The company was founded in 1960, and the CEO is Christian Wrabetz. | Finance |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Health Technology |
Brockmeyer Biopharma GmbH | |
Hexal Biotech Forschungs GmbH |
- Borsa valori
- Insiders
- Carsten Brockmeyer
- Esperienza